Medical Condition News

RSS

Laughter therapy eases breathlessness in people with COPD

A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce breathing difficulties and is as effective as more traditional breathing exercises. The research is presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

6 Sep 2026

AI chatbots wrongly reassure sleep apnea patients, study finds

In a third of cases, AI chatbots wrongly reassure sleep apnea patients that their symptoms are not serious, discouraging them from seeking a referral to a specialist, according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

6 Sep 2026

Genetic COPD risk emerges early with higher air pollution

Chronic obstructive pulmonary disease (COPD) is a serious, incurable lung disease that is common in older people.

6 Sep 2026

More Americans with disabilities found work despite broader employment decline

More Americans with disabilities were working in August, tying the record high reached in November 2025, even as employment among people without disabilities declined, according to today's National Trends in Disability Employment–Jobs Report (nTIDE), issued by Kessler Foundation and the University of New Hampshire's Institute on Disability.

4 Sep 2026

Autoimmune diseases form distinct genetic clusters, study finds

Different autoimmune diseases often share genetic risk factors, but not through a single common genetic vulnerability.

4 Sep 2026

Gut bacterial metabolite linked to inflammation in liver disease

Researchers have identified a link between specific activities in gut bacteria and the liver disease PSC.

4 Sep 2026

Dual-drug microneedle patch targets inflammation and fat browning

The worldwide obesity crisis has become a dominant public health crisis across the globe. Over 3 billion people worldwide currently suffer from obesity, and forecasts warn the number will rise above 4 billion by 2035, accounting for more than half the global population.

4 Sep 2026

Mosaic nanoparticle vaccine boosts broad mucosal coronavirus immunity

The persistent threat of emerging coronaviruses highlights the critical need to establish frontline defenses directly at the respiratory entry portal.

4 Sep 2026

MXene-based hydrogel offers dual-action treatment for periodontitis

Periodontitis is a highly prevalent chronic inflammatory disease worldwide. It leads to periodontal tissue destruction, alveolar bone resorption, and ultimately tooth loosening and loss, severely impacting patients' oral function and quality of life.

4 Sep 2026

Physics-informed AI framework improves aortic aneurysm stress prediction

Ascending thoracic aortic aneurysms often progress silently, but once dissection or rupture occurs, they can cause severe mortality before hospital arrival or during admission.

4 Sep 2026

Psilocybin study explores new treatment for cocaine use disorder

Albert Arias, MD, chief of addiction psychiatry at Carilion Clinic, has received an award from the National Institute on Drug Abuse (NIDA) to research how psilocybin, a psychedelic compound being studied for several psychiatric and substance use disorders, can offer a new approach for people with cocaine use disorder.

4 Sep 2026

Gut bacterial molecule discovered to drive serious bile duct disease

Researchers at the University of Oslo and Oslo University Hospital have, together with international collaborators, discovered that a small molecule made exclusively by gut bacteria can actively drive disease in the bile ducts and worsen primary sclerosing cholangitis (PSC), a serious liver and bile duct disease.

4 Sep 2026

Tumor environments sculpt diverse natural killer cells for cancer therapies

For decades, natural killer (NK) cells have been classified into two main groups based on surface markers: one specialized for cytokine production and the other for direct killing.

4 Sep 2026

Community brain health programs successfully improve attention in older adults

As aging populations drive rising global healthcare demands, finding scalable ways to prevent cognitive decline has become a vital public health priority.

4 Sep 2026

Most oncology AI research overlooks critical patient safety and privacy

Flinders University researchers were part of an international team that conducted a scoping review that identified 2,441 records and found just 32 studies examined how cancer patients, survivors and carers feel towards generative AI being used in their care.

4 Sep 2026

Researchers find greater microplastic burden in lung cancer patients

People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to research that will be presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

4 Sep 2026

Pig kidney xenotransplantation offers a bridge for patients awaiting human donor kidneys

In January 2026, Tim Andrews, who had received a genetically edited pig kidney in January 2025, became the recipient of a human kidney.

3 Sep 2026

As life expectancy rises, healthy aging is more important than ever

Global disease burden is shifting toward aging-related conditions as people live longer, with these diseases now representing the largest expected lifetime health burden for newborns across all income groups. Modeling suggests that reducing aging-related disease could produce unusually large and progressively greater gains in both longevity and healthy life expectancy because improvements in survival and health reinforce one another.

3 Sep 2026

ACC Quality Summit 2026 to focus on cardiovascular patient care improvements

The American College of Cardiology (ACC) Quality Summit 2026 will take place on September 16-18 in Orlando, connecting the cardiovascular quality improvement community to share ideas, learn from real-world successes and drive measurable improvements in the quality, safety and value of patient care.

3 Sep 2026